Date Filer Title Filing Type Shares Traded Price Total Held
Sep 01, 2020
Chaubey Alka
Chief Medical Officer
Trans History: 12
 Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Stewart Christopher P.
Chief Financial Officer
Trans History: 14
 Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 350,000 -- 350,000
Sep 01, 2020
Stewart Christopher P.
Chief Financial Officer
Trans History: 14
 Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 225,000 -- 225,000
Jun 30, 2020
BARKER DAVID L
Director
Trans History: 18
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
Jun 30, 2020
Linney Yvonne
Director
Trans History: 11
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
Jun 30, 2020
Luderer Albert
Director
Trans History: 11
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
Jun 30, 2020
Mamuszka Hannah
Director
Trans History: 9
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
Jun 30, 2020
TWOMEY CHRISTOPHER J
Director
Trans History: 14
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
Jun 30, 2020
Vuori Kristiina MD
Director
Trans History: 8
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
May 04, 2020
Linney Yvonne
Director
Trans History: 11
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 80,923 -- 80,923

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.